Several sources of information suggest that human beings evolved on a diet with a ratio of omega-6 to omega-3 essential fatty acids (EFA) of ~1 whereas in Western diets the ratio is 15/1–16.7/1. Western diets are deficient in omega-3 fatty acids, and have excessive amounts of omega-6 fatty acids compared with the diet on which human beings evolved and their genetic patterns were established. Excessive amounts of omega-6 polyunsaturated fatty acids (PUFA) and a very high omega-6/omega-3 ratio, as is found in today’s Western diets, promote the pathogenesis of many diseases, including cardiovascular disease, cancer, and inflammatory and autoimmune diseases, whereas increased levels of omega-3 PUFA (a lower omega-6/omega-3 ratio), exert suppressive effects. In the secondary prevention of cardiovascular disease, a ratio of 4/1 was associated with a 70% decrease in total mortality. A ratio of 2.5/1 reduced rectal cell proliferation in patients with colorectal cancer, whereas a ratio of 4/1 with the same amount of omega-3 PUFA had no effect. The lower omega-6/omega-3 ratio in women with breast cancer was associated with decreased risk. A ratio of 2–3/1 suppressed inflammation in patients with rheumatoid arthritis, and a ratio of 5/1 had a beneficial effect on patients with asthma, whereas a ratio of 10/1 had adverse consequences. These studies indicate that the optimal ratio may vary with the disease under consideration. This is consistent with the fact that chronic diseases are multigenic and multifactorial. Therefore, it is quite possible that the therapeutic dose of omega-3 fatty acids will depend on the degree of severity of disease resulting from the genetic predisposition. A lower ratio of omega-6/omega-3 fatty acids is more desirable in reducing the risk of many of the chronic diseases of high prevalence in Western societies, as well as in the developing countries.
Get full access to this article
View all access options for this article.
References
1.
Simopoulos AP, Childs B (Eds.). Genetic Variation and Nutrition. World Rev Nutr Diet. Basel: Karger, Vol. 63, 1990.
2.
Simopoulos AP, Robinson J. The Omega Diet. The Lifesaving Nutritional Program Based on the Diet of the Island of Crete. New York: HarperCollins, 1999.
3.
Simopoulos AP, Nestel PJ (Eds.). Genetic Variation and Dietary Response. World Rev Nutr Diet. Basel: Karger, Vol. 80, 1997.
4.
Simopoulos AP, Pavlou KN (Eds.). Nutrition and Fitness 1: Diet, Genes, Physical Activity and Health. World Rev Nutr Diet. Basel: Karger, Vol. 89, 2001.
5.
Simopoulos AP. Genetic variation and dietary response: nutrigenet-ics/nutrigenomics. Asia Pacific J Clin Nutr11(S6):S117–S128, 2002.
6.
Simopoulos AP, Ordovas JM (Eds.). Nutrigenetics and Nutrigenomics. World Rev Nutr Diet. Basel: Karger, Vol. 93, 2004.
7.
Eaton SB, Konner M. Paleolithic nutrition. A consideration of its nature and current implications. New Engl J Med312:283–289, 1985.
8.
Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr54:438–463, 1991.
9.
Simopoulos AP. Genetic variation and evolutionary aspects of diet. In: Papas A, Ed. Antioxidants in Nutrition and Health. Boca Raton: CRC Press, pp65–88, 1999.
10.
Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins, Leukotr Essent Fatty Acids60:421–429, 1999.
11.
Simopoulos AP. New products from the agri-food industry: The return of n-3 fatty acids into the food supply. Lipids34(suppl):S297–S301, 1999.
12.
Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med84:739–749, 1988.
13.
Eaton SB, Eaton SB III, Sinclair AJ, Cordain L, Mann NJ. Dietary intake of long-chain polyunsaturated fatty acids during the Paleolithic. World Rev Nutr Diet83:12–23, 1998.
14.
Leaf A, Weber PC. A new era for science in nutrition. Am J Clin Nutr45:1048–1053, 1987.
15.
Simopoulos AP. Overview of evolutionary aspects of w3 fatty acids in the diet. World Rev Nutr Diet83:1–11, 1998.
16.
Weber PC. Are we what we eat? Fatty acids in nutrition and in cell membranes: cell functions and disorders induced by dietary conditions. Svanoybukt, Norway: Svanoy Foundation (Report no. 4), pp9–18, 1989.
17.
Simopoulos AP. Evolutionary aspects of diet: fatty acids, insulin resistance and obesity. In: VanItallie TB, Simopoulos AP, Sr. Eds. Obesity: New Directions in Assessment and Management. Philadelphia: Charles Press, pp241–261, 1995.
18.
Simopoulos AP. Trans fatty acids. In: Spiller GA, Ed. Handbook of Lipids in Human Nutrition. Boca Raton: CRC Press, pp91–99, 1995.
19.
Simopoulos AP. Omega-3 fatty acids in inflammation an autoimmune diseases. J Am Coll Nutr21:495–505, 2002.
20.
Shannon J, King IB, Moshofskky R, Lampe JW, Li Gao D, Ray RM, Thomas DB. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr85:1090–1097, 2007.
21.
Hughes-Fulford M, Tjandrawinata RR, Li CF, Sayyah S. Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells. Carcinogenesis26:1520–1526, 2005.
22.
Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, Adolfsson J, Shahedi K, Xu J, Adami HO, Gronberg H, Balter KA. Association of frequent consumption of fatty fish with prostate cancer risk is modified by COX-2 polymorphism. Int J Cancer120:398–405, 2007.
23.
Hunter JE. Omega-3 fatty acids from vegetable oils. In: Galli C, Simopoulos AP, Eds. Biological Effects and Nutritional Essentiality. Series A: Life Sciences. New York: Plenum Press, Vol. 171:pp43–55, 1989.
24.
Litin L, Sacks F. Trans-fatty-acid content of common foods. N Engl J Med329:1969–1970, 1993.
25.
Raper NR, Cronin FJ, Exler J. Omega-3 fatty acid content of the US food supply. J Am College Nutr11:304, 1992.
26.
Ledger HP. Body composition as a basis for a comparative study of some East African animals. Symp Zool Soc London21:289–310, 1968.
27.
Crawford MA. Fatty acid ratios in free-living and domestic animals. Lancet i:1329–1333, 1968.
28.
Crawford MA, Gale MM, Woodford MH. Linoleic acid and linolenic acid elongation products in muscle tissue of Syncerus caffer and other ruminant species. Biochem J115:25–27, 1969.
29.
Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. Common purslane: a source of omega-3 fatty acids and antioxidants. J Am College Nutr11:374–382, 1992.
30.
Simopoulos AP, Norman HA, Gillaspy JE. Purslane in human nutrition and its potential for world agriculture. Basel: Karger, World Rev Nutr Diet77:47–74, 1995.
31.
Simopoulos AP, Salem N Jr. Purslane: a terrestrial source of omega-3 fatty acids. N Engl J Med315:833, 1986.
32.
Simopoulos AP, Gopalan C (Eds.). Plants in Human Health and Nutrition Policy. World Rev Nutr Diet. Basel: Karger, Vol. 91, pp47–74, 2003.
33.
Zeghichi S, Kallithrka S, Simopoulos AP, Kypriotakis Z. Nutritional composition of selected wild plants in the diet of Crete. World Rev Nutr Diet91:22–40, 2003.
34.
Simopoulos AP. Omega-3 fatty acids in wild plants, seeds and nuts. Asian Pacific J Clin Nutr11(S6):S163–S173, 2002.
35.
Simopoulos AP. Omega-3 fatty acids and antioxidants in edible wild plants. Biological Research37(2):263–277, 2004.
36.
Simopoulos AP, Salem N Jr. n-3 fatty acids in eggs from range-fed Greek chickens. N Engl J Med321:1412, 1989.
37.
Simopoulos AP, Salem N Jr. Egg yolk as a source of long-chain polyunsaturated fatty acids in infant feeding. Am J Clin Nutr55:411–414, 1992.
38.
van Vliet T, Katan MB. Lower ratio of n-3 to n-6 fatty acids in cultured than in wild fish. Am J Clin Nutr51:1–2, 1990.
39.
Cordain L, Martin C, Florant G, Watkins BA. The fatty acid composition of muscle, brain, marrow and adipose tissue in elk: evolutionary implications for human dietary requirements. World Rev Nutr Diet. Basel:Karger, Vol. 83, p. 225, 1998.
40.
Sinclair AJ, Slattery WJ, O’Dea K. The analysis of polyunsaturated fatty acids in meat by capillary gas-liquid chromotography. J Food Sci Agric33:771–776, 1982.
41.
Sugano M, Hirahara F. Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr71(suppl):189S–196S, 2000.
42.
Pella D, Dubnov G, Singh RB, Sharma R. Effects of an Indo-Mediterranean diet on the omega-6/omega-3 ratio in patients at high risk of coronary artery disease: the Indian paradox. Basel: Karger, World Rev Nutr Diet92:74–80, 2003.
43.
Sanders TAB. Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr71(suppl):S176–S178, 2000.
44.
de Gomez Dumm INT, Brenner RR. Oxidative desaturation of alpha-linolenic, linoleic, and stearic acids by human liver microsomes. Lipids10:315–317, 1975.
45.
Emken EA, Adlof RO, Rakoff H, Rohwedder WK. Metabolism of deuterium-labeled linolenic, linoleic, oleic, stearic and palmitic acid in human subjects. In: Baillie TA, Jones JR, Eds. Synthesis and Application of Isotopically Labeled Compounds 1988. Amsterdam: Elsevier Science Publishers, 713–716, 1989.
46.
Hague TA, Christoffersen BO. Effect of dietary fats on arachidonic acid and eicosapentaenoic acid biosynthesis and conversion to C22 fatty acids in isolated liver cells. Biochim Biophys Acta796:205–217, 1984.
47.
Hague TA, Christoffersen BO. Evidence for peroxisomal retrocon-version of adrenic acid (22:4n6) and docosahexaenoic acid (22:6n3) in isolated liver cells. Biochim Biophys Acta875:165–173, 1986.
48.
Indu M, Ghafoorunissa. N-3 fatty acids in Indian diets—comparison of the effects of precursor (alpha-linolenic acid) vs product (long chain n-3 polyunsaturated fatty acids). Nutr Res12:569–582, 1992.
49.
Carlson SE, Rhodes PG, Ferguson MG. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. Am J Clin Nutr44:798–804, 1986.
50.
Singer P, Jaeger W, Voigt S, Theil H. Defective desaturation and elongation of n-6 and n-3 fatty acids in hypertensive patients. Prostaglandins Leukot Med15:159–165, 1984.
51.
Honigmann G, Schimke E, Beitz J, Mest HJ, Schliack V. Influence of a diet rich in linolenic acid on lipids, thrombocyte aggregation and prostaglandins in type I (insulin-dependent) diabetes. Diabetologia 23: 175(abstract), 1982.
52.
Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr70(suppl):560S–569S, 1999.
53.
Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA87:3894–3898, 1990.
54.
Reaven P, Parthasarathy S, Grasse BJ, Miller E, Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL. Feasibility of using an oleate-rich diet to reduce the susceptibility of low density lipoprotein to oxidative modification in humans. Am J Clin Nutr54:701–706, 1991.
55.
Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb14:557–566, 1994.
56.
Louheranta AM, Porkkala-Sarataho EK, Nyyssonen MK, Salonen RM, Salonen JT. Linoleic acid intake and susceptibility of very-low-density and low-density lipoproteins to oxidation in men. Am J Clin Nutr63:698–703, 1996.
57.
Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet339:1183–1186, 1992.
58.
Cleland LG, James MJ, Neumann MA, D’Angelo M, Gibson RA. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr55:395–399, 1992.
59.
Liou YA, King J, Zibrik D, Innis SM. Decreasing linoleic acid with constant α-linolenic acid in dietary fats increases (n-3) eicosapenta-enoic acid in plasma phospholipids in healthy men. J Nutr137:945–952, 2007.
60.
Zampelas A, Paschos G, Rallidis L, Yiannakouris N. Linoleic acid to alpha-linolenic acid ratio. From clinical trials to inflammatory markers of coronary artery disease. World Rev Nutr Diet92:92–108, 2003.
61.
Ambring A, Johansson M, Axelsen M, Gan L, Strandvik B, Friberg P. Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr83:575–581, 2006.
62.
Simopoulos AP, Visioli F (Eds.). Mediterranean Diets. World Rev Nutr Diet. Basel: Karger, Vol. 87, 2000.
63.
Simopoulos AP, Visioli F (Eds.). More on Mediterranean Diets. World Rev Nutr Diet. Basel: Karger, Vol. 95, 2007.
64.
Freese R, Mutanen M, Valsta LM, Salminen I. Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb Haemost71:73–77, 1994.
65.
Simopoulos AP, Cleland LG (Eds.). Omega-6/Omega-3 Essential Fatty Acid Ratio: The scientific evidence. World Rev Nutr Diet. Basel: Karger, Vol. 92, 2003.
66.
Ferruci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, Martin A, Andres-Lacueva C, Senin U, Guralnik JM. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab91:439–446, 2006.
67.
Kang ZB, Ge Y, Chen Z, Brown J, Lapasota M, Leaf A, Kang JX. Adenoviral transfer of Caenorhabditis elegans n-3 fatty acid desaturase optimizes fatty acid composition in mammalian heart cells. Proc Natl Acad Sci USA98:4050–4054, 2001.
68.
Ge Y-L, Chen Z, Kang ZB, Cluette-Brown J, Laposata M, Kang JX. Effects of adenoviral transfer of Caenorhabditis elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Research22:537–544, 2002.
69.
Kang JX. The importance of omega-6/omega-3 fatty acid ratio in cell function. The gene transfer of omega-3 fatty acid desaturase. World Rev Nutr Diet92:23–36, 2003.
70.
Kang JX, Wang J, Wu L, Kang ZB. Fat-1 mice convert n-6 to n-3 fatty acids. Nature427:504, 2004.
71.
Kang JX. Balance of omega-6/omega-3 fatty acids is important for health: the evidence from gene transfer studies. World Rev Nutr Diet95:93–102, 2004.
72.
Lai L, Kang JX, Li R, Wang J, Witt WT, Yong HY, Hao Y, Was DM, Murphy CN, Rieke A, Samuel M, Linville ML, Korte SW, Evans RW, Starzl TE, Prather RS, Dai Y. Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol4:435–436, 2006.
73.
Kang JX. Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins Leukot Essent Fatty Acids77:263–267, 2007.
74.
Simopoulos AP. The role of fatty acids in gene expression: health implications. Ann Nutr Metab40:303–311, 1996.
75.
Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med350:29–37, 2004.
76.
de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin J-L, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet343:1454–1459, 1994.
77.
Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin JL, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr61(suppl):1360S–1367S, 1995.
78.
de Lorgeril M, Salen P. Modified Cretan Mediterranean diet in the prevention of coronary heart disease and cancer. World Rev Nutr Diet87:1–23, 2000.
79.
de Lorgeril M, Salen P. Modified Cretan Mediterranean diet in the prevention of coronary heart disease and cancer. An update. World Rev Nutr Diet97:1–32, 2007.
80.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet354:447–455, 1999.
81.
Li Y, Kang JX, Leaf A. Differential effects of various eicosanoids on the contraction of cultured neonatal rat cardiomyocytes. Prostaglandins54:511–530, 1997.
82.
Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM. Effect of changes in fat, fish and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet2:757–761, 1989.
83.
Singh RB, Rastogi SS, Verma R, Laxmi B, Singh R, Ghosh S, Niaz MA. Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ304:1015–1019, 1992.
84.
Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival—4. Cardiovasc Drugs Ther11: 485–491, 1997.
85.
Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D, Fatty Acid Antiarrhymnia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation112:2762–2768, 2005.
86.
Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrilators. A randomized controlled trial. JAMA293:2884–2891, 2005.
87.
Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimoda K, Shirata K, for the Japan EPA lipid intervention study (JELIS) Investigation. Effects of eicosapentaenoic acid on major coronary events in hypercholester-olaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet369:1090–1098, 2007.
88.
Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S; JPHC Study Group: Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese. The Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation113:195–202, 2006.
89.
Zhao G, Etherton TD, Martin KR, Gillies PJ, West SG, Kris-Etherton PM. Dietary α-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholester-olemic subjects. Am J Clin Nutr85:385–391, 2007.
90.
Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr. advance online publication 31 January 2007; doi: 10.1038/sj.ejcn.1602631:1–6, 2007.
91.
Kew S, Banerjee T, Minihane AM, Finnegan YE, Muggli R, Albers R, Williams CM, Calder PC. Lack of effect of foods enriched with plant-or animal-derived n-3 fatty acids on human immune function. Am J Clin Nutr77:1287–1295, 2003.
92.
Toborek M, Lee YW, Garrido R, Kaiser S, Hennig B. Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr75:119–125, 2002.
93.
Raheja BS, Sadikot SM, Phatak RB, Rao MB. Significance of the n-6/n-3 ratio for insulin action in diabetes. Ann NY Acad Sci683:258–271, 1993.
94.
James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum27:85–97, 1997.
95.
Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr65:1011–1017, 1997.
96.
Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis147:697–704, 1993.
97.
Bartram H-P, Bostner A, Scheppach W, Reddy BS, Rao CV, Dusel G, Richter F, Richteer A, Kasper H. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology105:1317–1322, 1993.
98.
Bartram H-P, Gostner A, Reddy BS, Rao CV, Scheppach W, Dusal G, Richter A, Richter F, Kasper H. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev4:231–237, 1995.
99.
Maillard V, Bougnoux P, Ferrari P, Jourdan M-L, Pinault M, Lavillonnieree FF, Body G, Le Floch O, Chajes V. N-3 and n-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer98:78–83, 2002.
100.
Eisman JA. Genetics of osteoporosis. Endocr Rev20:788–894, 1999.
101.
Seeman H, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerums G. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med320:554–558, 1989.
102.
Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. Risk factors for hip fracture in white women. Study of Osteoporosis Fracture Research Group. N Engl J Med332:767–773, 1995.
103.
Sakaguchi K, Morita I, Murota S. Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids50:81–84, 1994.
104.
Iwami-Morimoto Y, Yamaguchi K, Tanne K. Influence of dietary n-3 polyunsaturated fatty acid on experimental tooth movement in rats. Angle Orthod69:365–371, 1999.
105.
Li Y, Seifert MF, Ney DM, Grahn M, Grant AL, Allen KG, Watkins BA. Dietary conjugated linoleic acids alter serum IGF-1 and IGF binding protein concentrations and reduce bone formation in rats fed (n-6) or (n-3) fatty acids. J Bone Miner Res14:1153–1162, 1999.
106.
Das U. Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukot Essent Fatty Acids44: 201–210, 1991.
107.
Weiss LA, Barret-Connor E, von Muhlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr81:934–938, 2005.
108.
Hogstrom M, Nordstrom P, Nordstrom A. n-3 fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 study. Am J Clin Nutr85:803–807, 2007p.
109.
Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res18: 1206–1216, 2003.
110.
Watkins BA, Li Y, Lippman HE, Feng S. Modulatory effect of n-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids68:387–398, 2003.
111.
Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr62:1–9, 1995.
112.
Hibbeln JR, Umhau JC, Linnoila M George DT, Ragan PW, Shoaf SE, Vaughan MR, Rawlings R, Salem N Jr. A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids. Biol Psychiatry44:243–249, 1998.
113.
Hibbeln JR, Linnoila M, Umhau JC, Rawlings R, George DT, Salem N Jr. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry44:235–242, 1998.
114.
Maes M, Smith R, Christophe A, Cosyns P, Desnyder R, Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord38:35–46, 1996.
115.
Maes M, Smith R, Christophe A, Vandoolaeghe E, Van Gastel A, Neels H, Demedts P, Wauters A, Meltzer HY. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr Scand95:212–221, 1997.
116.
Peet M, Murphy B, Shay J, Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry43:315–319, 1998.
117.
Locke CA, Stoll AL. Omega-3 fatty acids in major depression. World Rev Nutr Diet89:173–185, 2001.
118.
Stoll AL, Severus WE, Freeman MP, Rueter S, Zboyan HA, Diamond E, Cress KK, Marangell LB. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry56:407–412, 1999.
119.
Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, Lemeshow S, Glaser R. Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosom Med Mar 30; (Epub ahead of print), 2007.
120.
Kunert KS, Tisdale AS, Stern ME, Smith JA, Gipson IK. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect of conjunctival lymphocytes. Arch Ophthalmol118:1489–1496, 2000.
121.
Marsh P, Pflugfelder SC. Topical nonpreserved methylprednisolone therapy for keratoconjuntivitis sicca in Sjogren syndrome. Ophthalmology106:811–816, 1999.
122.
Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro-and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Opthalmol Vis Sci42:2283–2292, 2001.
123.
Miljanovic B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr82: 887–893, 2005.
124.
Snow KK, Seddon JM. Do age-related macular degeneration and cardiovascular disease share common antecedents? Ophthalmic Epidemiol 6:125–143, 1999.
125.
Seddon JM, Chen CA. Epidemiology of age-related macular degeneration (4th ed.). In: Ryan SJ, Ed. Retina, Vol. 2: Medical Retina. St. Louis, MO: CV Mosby, 2005.
126.
Seddon JM, Hankinson S, Speizer F, Willett WC. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA276:1141–1146, 1996.
127.
Tomany SC, Wang JJ, van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology11:1280–1287, 2004.
Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, Willett W. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol119:1191–1199, 2001.
130.
Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol121:1728–1737, 2003.
131.
Cho E, Hung S, Willett W, Rimm EB, Seddon JM, Colditz GA, Hankinson SE. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr73:209–218, 2001.
132.
Smith W, Mitchell P, Leeder SR. Dietary fat and fish intake and age-related maculopathy. Arch Ophthalmol118:401–404, 2000.
133.
Seddon J, Ajani U, Sperduto R. Dietary fat intake and age-related macular degeneration (ARVO abstract). Invest Ophthalmol Vis Sci35:2003, 1994.
134.
Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration. The US Twin Study of age-related macular degeneration. Arch Ophthalmol124:995–1001, 2006.
